Thursday, May 1st, 2025

Keppel Ltd: Bullish Momentum Signals a Strong Buy Opportunity

Keppel Ltd Investment Recommendation: Buy

Technical Analysis of Keppel Ltd

  • Short-Term Outlook (1-2 weeks)
    • Recommendation: BUY based on technical analysis.
    • Recent Price Movement: The share price increased by 7.8% since its low of $5.75 in early August 2024.
    • Bullish Indicators:
      • The MACD chart shows a positive signal, with a bullish crossover where the MACD line (blue) crossed above the signal line (orange) in mid-August 2024.
      • The Relative Strength Index (RSI), currently at 56, indicates there is still room for further appreciation before reaching overbought territory (RSI > 70).
    • Resistance: Short-term price resistance is expected at $6.54, which aligns with the trend high observed on 18 July 2024.
    • Support: If price momentum turns negative, support is expected at $6.04, based on the daily low observed on 29 August 2024.
  • Medium-Term Outlook
    • Bullish Outlook:
      • Resistance: Medium-term resistance is at $7.00.
      • Support: Support is expected at $5.85.
  • Long-Term Outlook
    • Sideways Trend:
      • Resistance: At $7.25.
      • Support: At $5.65.
  • Company: Lim & Tan Securities
    Thank you

CapitaLand Investment, CapitaLand Integrated Commercial Trust, and Dyna-Mac Holdings – Key Investment Insights

CapitaLand Investment, CapitaLand Integrated Commercial Trust, and Dyna-Mac Holdings – Key Investment Insights CapitaLand Investment Limited (SGX: 9CI): Strategic Asset Recycling for Growth Recommendation: BUY Target Price: S$3.50 Date of Recommendation: September 3, 2024...

Singapore Exchange (SGX SP): Navigating Market Volatility and Sustaining Growth

Singapore Exchange (SGX SP): Navigating Market Volatility and Sustaining Growth Overview: Singapore Exchange (SGX) is a leading multi-asset exchange, providing listing, trading, clearing, settlement, depository, and data services across equity, fixed income, and derivatives...

CSPC Innovation Pharmaceutical Co Eyes Growth with Strategic Acquisition and Promising R&D Achievements

Date: October 18, 2024Broker: UOB Kay Hian Private Limited Company Overview CSPC Innovation Pharmaceutical Co is a producer of functional raw materials and health food, transforming into a leading drug innovator in China. The...